Tag: NANDINI PIRAMAL

According to chairperson Nandini Piramal, Piramal Pharma will expand its injectables pipeline to enhance growth. The company launched Chlorpromazine Hydrochloride recently, with its complex hospital generics business seeing a 14% growth in Q3. Reports indicate their share in inhalation anesthetics and a focus on new products suggest promising future revenue, aiming for $2 billion by…